Article · 28 Feb 2025
Conference abstract
Attacking bacterial pathogens using nanoparticle-based approaches: Steps and hurdles
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The challenge of antibiotic-resistant infections (ARI) extends to global scales. New antibiotics having novel mechanisms of action and more-efficient delivery approaches to infections are needed to slow the climb in this emerging crisis. Engineered nanoparticles (NP) have been successfully used in eukaryotic systems, including humans for drug delivery purposes. Their applications to the microbial realm for delivery of antibiotics and other antimicrobials has remained steps behind due to methodological limitations, and the physiological properties and defenses of bacteria. The present talk will overview some recent advances toward attacking and manipulating bacterial cells to illustrate (hopefully) how engineered NPs can be used to obviate the seemingly strong defenses used by bacteria in pathogen infections. Specifically addressed topics will be: enhancing current antibiotic efficacy with molecular enhancers; attaching multiple antibiotics to NPs; and NP-antibiotic entry into bacterial cells. Major obstacles exist in nano-based approaches and negate the ‘one solution fits all’ approach using NPs. A first broad obstacle is how to specifically target the pathogens of interest, while not significantly impacting the 1–2 kg of ‘good’ bacteria that humans typically possess and require to varying extents. A further complication is in the adaptability of bacterial surface signatures, and their capability to ‘hide’ within protective biofilms. A third obstacle addresses the selection of resistant variants to any antimicrobial attack. These and other issues for consideration will be addressed at teh conference.
Keywords
Subjects
Infectious DiseasesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 1 Sep 2017
Nanoparticle-based vaccine platforms against apicomplexan
Conference abstract
Multiple approaches to Stenotrophomonas maltophilia, a global human opportunist and multiple-drugresistant bacterial pathogen
Conference abstract
Strategy for developing a molecular sub typing tool for a food borne bacterial pathogen using a whole genome analysis approach: The case of Salmonella Enteritidis
Conference abstract
A multidisciplinary approach to characterizing virulence determinants in bacterial pathogens
More from this journal
The newest in Journal of Infectious Diseases and Treatment.
Article · 13 Jan 2025
Balancing Act: Differential Effects of Antiparasitics on Microbiota Resilience
Article · 13 Jan 2025
The Graph Show the Annual Income of Language-Related Jobs in US Dollars in Five Cities
Article · 30 Dec 2024
Leveraging Shared Omics Architecture to Uncover Causal Relationships Between Complex Traits and COVID-19
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Infectious Diseases and Treatment
- SubjectInfectious Diseases
- BylineArticles whose byline prints “Alan W Decho”
